Currently, RexSoft is preparing a service that calculates disease risk using genetic information.
Individual genes will be genotyped using next-generation sequencing and SNP array technology.
Genetic risk of disease will be calculated with (i) gene amplification technology, which will use genotype data of adjacent sequences for sequences
that do not have genotype information available, and (ii) disease prediction technology, which will use genetic information.

Through this service, RexSoft strives to provide a more accurate health assessment by
calculating the risk of various diseases, including cancer, Alzheimer's, and obesity.
Overall, we expect that more effective healthcare will be possible with the use of these accurately-calculated disease risks.